|
1
|
Cong M, Liu T, Wang P, Fan X, Yang A, Bai
Y, Peng Z, Wu P, Tong X, Chen J, et al: Antifibrotic effects of a
recombinant adeno-associated virus carrying small interfering RNA
targeting TIMP-1 in rat liver fibrosis. Am J Pathol. 182:1607–1616.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xu G, Niki T, Virtanen I, Rogiers V, De
Bleser P and Geerts A: Gene expression and synthesis of fibronectin
isoforms in rat hepatic stellate cells. Comparison with liver
parenchymal cells and skin fibroblasts. J Pathol. 183:90–98. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Matsui S, Takahashi T, Oyanagi Y,
Takahashi S, Boku S, Takahashi K, Furukawa K, Arai F and Asakura H:
Expression, localization and alternative splicing pattern of
fibronectin messenger RNA in fibrotic human liver and
hepatocellular carcinoma. J Hepatol. 27:843–853. 1997. View Article : Google Scholar
|
|
4
|
Sottile J and Hocking DC: Fibronectin
polymerization regulates the composition and stability of
extracellular matrix fibrils and cell-matrix adhesions. MolBiol
Cell. 13:3546–3559. 2002.
|
|
5
|
Velling T, Risteli J, Wennerberg K, Mosher
DF and Johansson S: Polymerization of type I and III collagens is
dependent on fibronectin and enhanced by integrins alpha 11beta 1
and alpha 2beta 1. J Biol Chem. 277:37377–37381. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Roeb E and Matern S: Fibronectin-a key
substance in pathogenesis of liver cirrhosis? Leber Magen Darm.
23:239–242. 1993.In German. PubMed/NCBI
|
|
7
|
Manabe R, Oh-e N and Sekiguchi K:
Alternatively spliced EDA segment regulates fibronectin-dependent
cell cycle progression and mitogenic signal transduction. J Biol
Chem. 274:5919–5924. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Krzyzanowska-Gołab D, Lemańska-Perek A and
Katnik-Prastowska I: Fibronectin as an active component of the
extracellular matrix. Postepy Hig Med Dosw (Online). 61:655–663.
2007.In Polish.
|
|
9
|
Leite AR, Corrêa-Giannella ML, Dagli ML,
Fortes MA, Vegas VM and Giannella-Neto D: Fibronectin and laminin
induce expression of islet cell markers in hepatic oval cells in
culture. Cell Tissue Res. 327:529–537. 2007. View Article : Google Scholar
|
|
10
|
Mòdol T, Brice N, Ruiz de Galarreta R,
García Garzón A, Iraburu MJ, Martínez-Irujo JJ and López-Zabalza
MJ: Fibronectin peptides as potential regulators of hepatic
fibrosis through apoptosis of hepatic stellate cells. J Cell
Physiol. 230:546–553. 2015. View Article : Google Scholar
|
|
11
|
Kawelke N, Vasel M, Sens C, Av A, Dooley S
and Nakchbandi IA: Fibronectin protects from excessive liver
fibrosis by modulating the availability of and responsiveness of
stellate cells to active TGF-β. PLoS One. 6:e281812011. View Article : Google Scholar
|
|
12
|
Altrock E, Sens C, Wuerfel C, Vasel M,
Kawelke N, Dooley S, Sottile J and Nakchbandi IA: Inhibition of
fibronectin deposition improves experimental liver fibrosis. J
Hepatol. 62:625–633. 2015. View Article : Google Scholar
|
|
13
|
Parsons CJ, Takashima M and Rippe RA:
Molecular mechanisms of hepatic fibrogenesis. J Gastroenterol
Hepatol. 22(Suppl 1): S79–S84. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Inagaki Y and Okazaki I: Emerging insights
into Transforming growth factor beta Smad signal in hepatic
fibrogenesis. Gut. 56:284–292. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Reitman S and Frankel S: A colorimetric
method for the determination of serum glutamic oxalacetic and
glutamic pyruvic transaminases. Am J Clin Pathol. 28:56–63. 1957.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta DeltaC(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
17
|
Zhang X, Yang J, Li Y and Liu Y: Both Sp1
and Smad participate in mediating TGF-beta1-induced HGF receptor
expression in renal epithelial cells. Am J Physiol Renal Physiol.
288:F16–F26. 2005. View Article : Google Scholar
|
|
18
|
Ruwart MJ, Wilkinson KF, Rush BD, Vidmar
TJ, Peters KM, Henley KS, Appelman HD, Kim KY, Schuppan D and Hahn
EG: The integrated value of serum procollagen III peptide over time
predicts hepatic hydroxyproline content and stainable collagen in a
model of dietary cirrhosis in the rat. Hepatology. 10:801–806.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lan HY, Mu W, Nikolic-Paterson DJ and
Atkins RC: A novel, simple, reliable, and sensitive method for
multiple immunoenzyme staining: Use of microwave oven heating to
block antibody crossreactivity and retrieve antigens. J Histochem
Cytochem. 43:97–102. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Carpino G, Morini S, Ginanni Corradini S,
Franchitto A, Merli M, Siciliano M, Gentili F, Onetti Muda A,
Berloco P, Rossi M, et al: Alpha-SMA expression in hepatic stellate
cells and quantitative analysis of hepatic fibrosis in cirrhosis
and in recurrent chronic hepatitis after liver transplantation. Dig
Liver Dis. 37:349–356. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sohrabpour AA, Mohamadnejad M and
Malekzadeh R: Review article: The reversibility of cirrhosis.
Aliment Pharmacol Ther. 36:824–832. 2012.PubMed/NCBI
|
|
22
|
Brenner DA: Reversibility of liver
fibrosis. Gastroenterol Hepatol (N Y). 9:737–739. 2013.
|
|
23
|
Bataller R and Brenner DA: Liver fibrosis.
J Clin Invest. 115:209–218. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Foo NP, Lin SH, Lee YH, Wu MJ and Wang YJ:
α-Lipoic acid inhibits liver fibrosis through the attenuation of
ROS-triggered signaling in hepatic stellate cells activated by PDGF
and TGF-α. Toxicology. 282:39–46. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Friedman SL: Hepatic stellate cells:
Protean, multifunctional, and enigmatic cells of the liver. Physiol
Rev. 88:125–172. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bae MA, Rhee SD, Jung WH, Ahn JH, Song BJ
and Cheon HG: Selective inhibition of activated stellate cells and
protection from carbon tetrachloride-induced liver injury in rats
by a new PPARgamma agonist KR62776. Arch Pharm Res. 33:433–442.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Svegliati-Baroni G, De Minicis S and
Marzioni M: Hepatic fibrogenesis in response to chronic liver
injury: Novel insights on the role of cell-to-cell interaction and
transition. Liver Int. 28:1052–1064. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Meindl-Beinker NM and Dooley S:
Transforming growth factor-beta and hepatocyte transdifferentiation
in liver fibrogenesis. J Gastroenterol Hepatol. 23(Suppl 1):
S122–S127. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Arauz J, Zarco N, Segovia J, Shibayama M,
Tsutsumi V and Muriel P: Caffeine prevents experimental liver
fibrosis by blocking the expression of TGF-β. Eur J Gastroenterol
Hepatol. 26:164–273. 2014. View Article : Google Scholar
|
|
30
|
Gressner AM and Weiskirchen R: Modern
pathogenetic concepts of liver fibrosis suggest stellate cells and
TGF-beta as major players and therapeutic targets. J Cell Mol Med.
10:76–99. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mosesson MW: Fibrinogen and fibrin and
structure and functions. J Thromb Haemost. 3:1894–1904. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wielockx B, Lannoy K, Shapiro SD, Itoh T,
Itohara S, Vandekerckhove J and Libert C: Inhibition of matrix
metalloproteinases blocks lethal hepatitis and apoptosis induced by
tumor necrosis factor and allows safe antitumor therapy. Nat Med.
7:1202–1208. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Leu JI, Crissey MA and Taub R: Massive
hepatic apoptosis associated with TGF-beta1 activation after Fas
ligand treatment of IGF binding protein-1-deficient mice. J Clin
Invest. 111:129–139. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kandemir O, Polat G, Sahin E, Bagdatoglu
O, Camdeviren H and Kaya A: Fibronectin levels in chronic viral
hepatitis and response of this protein to interferon therapy.
Hepatogastroenterology. 51:811–814. 2004.PubMed/NCBI
|
